Trials / Completed
CompletedNCT00581542
Moxifloxacin vs. Polytrim for Conjunctivitis
A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution for Treatment of Conjunctivitis.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- University of Rochester · Academic / Other
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | moxifloxacin | 1-2 drops three times a day for 8-10 days. |
| DRUG | polytrim | 1-2 drops four times a day for 8-10 days. |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2009-03-01
- Completion
- 2012-03-01
- First posted
- 2007-12-27
- Last updated
- 2016-01-18
- Results posted
- 2016-01-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00581542. Inclusion in this directory is not an endorsement.